Proteasome Inhibitors Market Forecast 2025–2034: Trends Reshaping Demand, Investment, and Innovation
Discover trends, market shifts, and competitive outlooks for the pruritus therapeutics industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research
How Has the Pruritus Therapeutics Market Growth Performance Trended Historically, And What Lies Ahead?
The market for pruritus therapeutics has seen robust expansion in the past few years. Its size is predicted to escalate from $11.89 billion in 2024 to $12.51 billion in 2025, showcasing a compound annual growth rate (CAGR) of 5.3%. Factors influencing this growth trend in the historic period include an increase in pruritus cases, a variety of causes and conditions, a surge in the elderly population, and an emphasis on improving patient’s quality of life.
The market for pruritus therapeutics is forecasted to experience substantial growth in the coming years, with an estimated value of $16.05 billion by 2029 and a compound annual growth rate (CAGR) of 6.4%. Several factors will drive this anticipated growth, including a growing understanding of pruritus pathophysiology, innovation in drug formulations and delivery methods, an emphasis on personalized medicine, an increase in dermatological R&D, increased diagnosis rates, and a rising interest in plant-based and herbal treatments. Other key trends expected during this forecast period are the creation of itch-specific receptor agonists and antagonists, a market shift towards personalized therapeutic approaches, the inclusion of advanced technology in itch tracking and management, and increased collaboration for interdisciplinary research.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11907&type=smp
What Are the Primary Drivers Supporting the Market Growth of the Pruritus Therapeutics Market?
An increase in dermatological conditions is anticipated to boost the expansion of the pruritus therapeutics market. Dermatological conditions are an array of disorders affecting the skin, hair, nails, and mucous membrane; from acne and eczema to skin cancer and fungal infections. The choice of pruritus treatments for skin diseases is often guided by the underlying cause of the itch. Topical treatments, emollients and moisturizers, immunosuppressive drugs, and treatments specifically for itching are all options to manage this condition. For example, in January 2024, the American Cancer Society, a non-profit organization in the US with a mission to eradicate cancer, projected 108,270 skin cancer cases. This represented a 3.2% increase from the 104,930 cases reported in 2023. Consequently, the upsurge in the occurrence of dermatological conditions is steering the growth of the pruritus therapeutics market.
Which Primary Segments of the Pruritus Therapeutics Market Are Driving Growth and Industry Transformations?
The pruritus therapeutics market covered in this report is segmented –
1) By Product: Corticosteroids, Antihistamines, Local Anesthetics, Counterirritants, Immunosuppressants, Calcineurin Inhibitors, Other Products
2) By Route Of Administration: Oral, Parenteral, Topical
3) By Disease Type: Atopic Dermatitis, Allergic Contact Dermatitis, Urticaria, Cutaneous T-Cell, Other Disease Types
4) By End-User: Hospitals, Clinics, Other End Users
Subsegments:
1) By Corticosteroids: Topical Corticosteroids, Systemic Corticosteroids
2) By Antihistamines: First-Generation Antihistamines, Second-Generation Antihistamines
3) By Local Anesthetics: Topical Local Anesthetics
4) By Counterirritants: Menthol-Based Products, Camphor-Based Products
5) By Immunosuppressants: Topical Immunosuppressants, Systemic Immunosuppressants
6) By Calcineurin Inhibitors: Tacrolimus Ointment, Pimecrolimus Cream
7) By Other Products: Moisturizers And Emollients, Antipruritic Herbal Remedies, Combination Therapies
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=11907&type=smp
Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of the Pruritus Therapeutics Market?# Market?
North America was the largest region in the pruritus treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pruritus therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Most Significant Market Trends in the Pruritus Therapeutics Market?
Leading firms in the pruritus therapeutics market are concentrating on creating customized treatments for specific patient groups and rare diseases, like the non-systemic ileal bile acid transport inhibitor to offer individualized medicine addressing unaddressed healthcare needs. This specific drug type homes in on bile acid absorption in the intestine without greatly influencing the systemic circulation, hence reducing possible side effects. For example, in June 2023, Ipsen, a pharmaceutical company based in France, was granted approval by the Food and Drug Administration (FDA), the US federal agency under the Department of Health and Human Services, for Bylvay (odevixibat) to cure cholestatic pruritus in patients who are 12 months or older and suffer from Alagille syndrome (ALGS). Bylvay, an everyday, non-systemic ileal bile acid transport inhibitor (IBATi) with minimal systemic exposure, is the pioneering drug approved for cholestatic pruritus due to progressive familial intrahepatic cholestasis (PFIC) in America. Prior to this, it had been approved for PFIC treatment in Europe and is currently accessible via prescription for suitable ALGS patients.
View the full report here:
https://www.thebusinessresearchcompany.com/report/pruritus-therapeutics-global-market-report
What Parameters Are Used to Define the Pruritus Therapeutics Market?
Pruritus therapeutics refers to the treatments used to address an unpleasant skin sensation that causes an urge to scratch. This treatment is commonly used to stop swelling and inflammation in moderate-to-severe inflammatory skin diseases.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11907
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model